NCT06505889

Brief Summary

The objective of this clinical trial is to investigate if local anesthesia using topical analgesic drug (10% lidocaine spray) or cryo-analgesic (Ice pack) can reduce pain levels during and after arterial blood sampling procedure. The research questions of this study includes:

  • Can local anesthesia using topical analgesic drug (10% lidocaine spray) or cryo-analgesic (Ice pack) reduce pain levels during arterial blood sampling?
  • Is the first-attempt success rate of arterial blood sampling higher when using local anesthesia (lidocaine spray or ice pack) compared to standard practice without anesthesia?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 17, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

May 11, 2025

Status Verified

May 1, 2025

Enrollment Period

3 months

First QC Date

July 1, 2024

Last Update Submit

May 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain score both during and after the arterial blood sampling procedure.

    Pain score will be assessed using a horizontal numeric Rating Scale (NRS) ranging from 0 to 10, with 0 representing "no pain" and 10 representing "the worst pain."

    Participants will rate their pain score both during and at 30 seconds after the arterial blood sampling procedure.

Secondary Outcomes (2)

  • The first-attempt success rate for arterial blood sampling procedure when using local anesthesia.

    During the arterial blood sampling procedure.

  • explore the relationship between associated factors and overall time for arterial blood draw.

    procedure time was recorded since intervention was performed by physician. end point is when physician withdraw an ABG needle from patient skin.

Study Arms (3)

Cryo-analgesic group (Ice pack)

EXPERIMENTAL

A standard cold pack chilled to -4°C will be applied to the arterial puncture site for 2 minutes. Following antiseptic cleaning and the physician will immediately perform the arterial blood sampling procedure with heparinized 3mL arterial blood gas syringe with a 22G x 1" needle.

Other: Local anesthesia methods

Analgesic drug group (10% lidocaine spray)

EXPERIMENTAL

10% lidocaine spray will be applied to the puncture site, covering a circular area (2-3 cm radius) around the puncture site for 2 minutes. Following antiseptic cleaning and the physician will immediately perform the arterial blood sampling procedure with heparinized 3mL arterial blood gas syringe with a 22G x 1" needle.

Other: Local anesthesia methods

Control group (2% Chlorhexidine alcohol)

NO INTERVENTION

This group will receive standard antiseptic preparation with chlorhexidine in alcohol applied in a circular area (2-3 cm radius) around the puncture site for 2 minutes. Following antiseptic cleaning and the physician will immediately perform the arterial blood sampling procedure with heparinized 3mL arterial blood gas syringe with a 22G x 1" needle.

Interventions

Local pain control method before arterial blood sampling procedure

Analgesic drug group (10% lidocaine spray)Cryo-analgesic group (Ice pack)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years or older, who present to the emergency department of Queen Savang Vadhana Memorial Hospital that requires arterial blood sampling procedure for diagnostic purposes

You may not qualify if:

  • Altered level of consciousness (Glasgow Coma Scale \< 15)
  • Cognitive impairment or communication barriers precluding accurate pain assessment (e.g., severe dementia, aphasia, intoxication, delirium)
  • Contraindications to radial artery cannulation (e.g., severe peripheral vascular disease, history of arteriovenous fistula at the puncture site, active infection at the puncture site)
  • Pregnancy
  • Need for emergency management which any delay could worsen patient care (e.g., cardiac arrest, respiratory failure requiring immediate intubation)
  • Known allergy or hypersensitivity to lidocaine or amide-type local anesthetics
  • Severe pain from other sources that could distracting pain assessment related to the arterial blood sampling procedure (e.g., significant trauma, bone fractures, severe burns)
  • Failure to obtain successful arterial access after two attempts by an experienced operator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Savang Vadhana Memorial Hospital

Chon Buri, 20110, Thailand

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Chawin Taveekijakarn, MD

    QSMVH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be assigned to one of three study groups (A, B, or C) to receive different local anesthesia methods prior to arterial blood sampling: Group A (Ice pack), Group B (10% lidocaine spray), Group C (Control)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2024

First Posted

July 17, 2024

Study Start

July 1, 2024

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

May 11, 2025

Record last verified: 2025-05

Locations